Back to Capital Research Global Investors

VRTX
Showing 8 of 13 quarters

Position history for Capital Research Global Investors's holdings in VERTEX PHARMACEUTICALS INC

Capital Research Global Investors holds 21.1M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $9.4B as of 2026-Q1. The position was increased (+22.0% shares). VRTX represents 1.5% of Capital Research Global Investors's portfolio.

Current Value

$9.4B

Current Shares

21.1M

Total Value Change

+$5.4B

Total Shares Change

+12.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
21.1M
+22.0%
$9.4B1.5%$474.27
60
2025-Q4
Increased
17.3M
+4.6%
$7.9B1.4%$453.74
53
2025-Q3
Increased
16.6M
+2.8%
$6.5B1.2%$395.31
52
2025-Q2
Increased
16.1M
+10.8%
$7.2B1.4%$441.30
56
2025-Q1
Increased
14.5M
+39.4%
$7B1.5%$492.69
66
2024-Q4
Increased
10.4M
+15.8%
$4.2B0.9%$399.35
52
2024-Q3
Increased
9M
+5.4%
$4.2B0.9%$462.88
47
2024-Q2
Increased
8.5M
+48.7%
$4B0.9%$468.72
62

Other major holders of VRTX: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used